Author Bio
Joe honed his investing skills as an analyst for Stock Advisor, Supernova, and Fool One. He battle-tested his investment philosophy and strategies as portfolio manager of Tier 1, a market-crushing Motley Fool real-money portfolio that delivered 24.58% annualized returns during its existence. Now, Joe’s mission is to pass on what he’s learned and what he continues to learn as a contributing writer to Fool.com.
Follow @Tier1Investor
Innovative Industrial Properties (NYSE:IIPR) offers investors a way to profit from the marijuana industry s expansion while collecting hefty dividends along the way. For these reasons, IIP s stock has proven popular among sophisticated investors.
Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
As it did with most elements of our lives, the coronavirus pandemic had a withering effect on many stocks in 2020. Companies in more than a few sectors suddenly had to contend with stay-at-home orders and mandatory business closures, a challenging set of circumstances for which few were prepared.
Author Bio
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi
Amidst the rollout of coronavirus vaccines, continuing economic fallout from the pandemic, and a new administration in the U.S., there s plenty of uncertainty to go around. Nonetheless, in the last six months, the
S&P 500 has grown substantially, and some people expect 2021 to usher in a bull market.
Aphria (NASDAQ:APHA) and
Tilray (NASDAQ:TLRY). Benzinga spoke with Aphria CEO and chairman
Irwin D. Simon, who will maintain those two positions in the new company, and Tilray CEO
Brendan Kennedy, who will serve in the new corporation’s board of directors. The executives shared details on how the deal came to be, and their expectations for the future, which, they say, doesn’t include massive layoffs.
Cantor Fitzgerald’s analyst Pablo Zuanic praised the merger. The Canadian cannabis sector is in need of consolidation due to the oversupply problems and “historically low flower retail prices,” he explained.
Green Market Report CEO Debra Borchardt told Benzinga the Aphria/Tilray merger “was certainly a good deal for Tilray shareholders, while the Aphria shareholders will probably have to wait a bit before they see the benefits of this deal. The combined company will definitely be a powerhouse of revenue, there is no question about that.”
SPAC
Email
Thank You
Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com Start Investing